Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Biology of EWS/ETS fusions in Ewing's family tumors

Abstract

Tumor-associated chromosomal translocations lead to the formation of chimeric fusions between the EWS gene and one of five different ETS transcription factors in Ewing's family tumors (EFTs). The resultant EWS/ETS proteins promote oncogenesis in a dominant fashion in model systems and are necessary for continued growth of EFT cell lines. EWS belongs to a family of genes that encode proteins that may serve as adapters between the RNA polymerase II complex and RNA splicing factors. EWS/ETS fusions have biochemical characteristics of aberrant transcription factors and appear to promote abnormal cellular growth by transcriptionally modulating a network of target genes. Early evidence suggests that EWS/ETS proteins may also impact gene expression through alteration in RNA processing. Elucidation of EWS/ETS target gene networks in the context of other signaling pathways will hopefully lead to biology based therapeutic strategies for EFT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Athanasiou M, Clausen PA, Mavrothalassitis GJ, Zhang XK, Watson DK, Blair DG . 1996 Cell Growth Differ. 7: 1525–1534

  • Attwooll C, Tariq M, Harris M, Coyne JD, Telford N, Varley JM . 1999 Oncogene 18: 7599–7601

  • Aurias A, Rimbaut C, Buffe D, Zucker JM, Mazabraud A . 1984 Cancer Genet. Cytogenet. 12: 21–25

  • Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G, Ghysdael J . 1994 Mol. Cell. Biol. 14: 3230–3241

  • Bastian LS, Kwiatkowski BA, Breininger J, Danner S, Roth G . 1999 Blood 93: 2637–2644

  • Bertolotti A, Lutz Y, Heard DJ, Chambon P, Tora L . 1996 EMBO J. 15: 5022–5031

  • Bertolotti A, Melot T, Acker J, Vigneron M, Delattre O, Tora L . 1998 Mol. Cell. Biol. 18: 1489–1497

  • Blair DG, Athanasiou M . 2000 Oncogene 19: 6472–6481

  • Brown LA, Rodaway AR, Schilling TF, Jowett T, Ingham PW, Patient RK, Sharrocks AD . 2000 Mech. Dev. 90: 237–252

  • Burchill SA, Wheeldon J, Cullinane C, Lewis IJ . 1997 Eur. J. Cancer 33: 239–243

  • Cavazzana AO, Miser JS, Jefferson J, Triche TJ . 1987 Am. J. Path. 127: 507–518

  • Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, Crew J, Gusterson BA, Shipley J, Cooper CS . 1996 Oncogene 12: 229–235

  • Crozat A, Aman P, Mandahl N, Ron D . 1993 Nature (Lond.) 363: 640–644

  • Dalgleish P, Sharrocks AD . 2000 Nucleic Acids Res. 28: 560–569

  • Darby TG, Meissner JD, Ruhlmann A, Mueller WH, Scheibe RJ . 1997 Oncogene 15: 3067–3082

  • de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PH, Barr FG, Ladanyi M . 1998 J. Clin. Oncol. 16: 1248–1255

  • Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Thomas G . 1994 N. Engl. J. Med. 331: 294–299

  • Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G . 1992 Nature 359: 162–165

  • Deloulme JC, Prichard L, Delattre O, Storm DR . 1997 J. Biol. Chem. 272: 27369–27377

  • Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Roméo PH, Mignotte V . 1996 Blood 87: 4678–4685

  • Dhulipala PD, Lee L, Rao VN, Reddy ES . 1998 Oncogene 17: 1149–1157

  • Felsch JS, Lane WS, Peralta EG . 1999 Curr. Biol. 9: 485–488

  • Fitzsimmons D, Hodsdon W, Wheat W, Maira SM, Wasylyk B, Hagman J . 1996 Genes Dev. 10: 2198–2211

  • Graves BJ, Petersen JM . 1998 Adv. Cancer Res. 75: 1–55

  • Guinamard R, Fougereau M, Seckinger P . 1997 Scand. J. Immunol. 45: 587–595

  • Hahm KB . 1999 Nat. Genet. 23: 481

  • Hallier M, Lerga A, Barnache S, Tavitian A, Moreau-Gachelin F . 1998 J. Biol. Chem. 273: 4838–4842

  • Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R, Bernstein A . 2000 Immunity 13: 167–177

  • Hicks GG, Singh N, Nashabi A, Mai S, Bozek G, Klewes L, Arapovic D, White EK, Koury MJ, Oltz EM, Van Kaer L, Ruley HE . 2000 Nature Genet. 24: 175–179

  • Ichikawa H, Shimizu K, Hayashi Y, Ohki M . 1994 Cancer Res. 54: 2865–2868

  • Im YH, Kim HT, Lee C, Poulin D, Welford S, Sorensen PH, Denny CT, Kim SJ . 2000 Cancer Res. 60: 1536–1540

  • Immanuel D, Zinszner H, Ron D . 1995 Mol. Cell. Biol. 15: 4562–4571

  • Jaishankar S, Zhang J, Roussel MF, Baker SJ . 1999 Oncogene 18: 5592–5597

  • Javelaud D, Wietzerbin J, Delattre O, Besancon F . 2000 Oncogene 19: 61–68

  • Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN . 1995 Oncogene 10: 1229–1234

  • Kaneko Y, Yoshida K, Handa M, Toyoda Y, Nishihira H, Tanaka Y, Sasaki Y, Ishida S, Higashino F, Fujinaga K . 1996 Genes, Chrom. Cancer 15: 115–121

  • Knoop LL, Baker SJ . 2000 J. Biol. Chem. 275: 24865–24871

  • Kontny HU, Lehrnbecher TM, Chanock SJ, Mackall CL . 1998 Cancer Res. 58: 5842–5849

  • Kovar H, Aryee DN, Jug G, Henockl C, Schemper M, Delattre O, Thomas G, Gadner H . 1996 Cell Growth Differ. 7: 429–437

  • Kovar H, Dworzak M, Strehl S, Schnell E, Ambros IM, Ambros PF, Gadner H . 1990 Oncogene 5: 1067–10670

  • Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H . 1997 Oncogene 15: 2225–2232

  • Kuroda M, Sok J, Webb L, Baechtold H, Urano F, Yin Y, Chung P, de Rooij DG, Akhmedov A, Ashley T, Ron D . 2000 EMBO J. 19: 453–462

  • Kwiatkowski BA, Bastian LS, Bauer TR, Tsai S, Zielinska-Kwiatkowska AG, Hickstein DD . 1998 J. Biol. Chem. 273: 17525–17530

  • Kwiatkowski BA, Zielinska-Kwiatkowska AG, Bauer TR, Hickstein DD . 2000 Blood Cells Mol. Dis. 26: 84–90

  • Labelle Y, Zucman J, Stenman G, Kindblom LG, Knight J, Turc-Carel C, Dockhorn-Dworniczak B, Mandahl N, Desmaze C, Peter M, Aurias A, Delattre O, Thomas G . 1995 Hum. Mol. Gen. 4: 2219–2226

  • Ladanyi M, Gerald W . 1994 Cancer Res. 54: 2837–2840

  • Lambert G, Bertrand JR, Fattal E, Subra F, Pinto-Alphandary H, Malvy C, Auclair C, Couvreur P . 2000 Biochem. Biophys. Res. Commun. 279: 401–406

  • Lessnick SL, Braun BS, Denny CT, May WA . 1995 Oncogene 10: 423–431

  • Li R, Huiping P, Watson DK . 2000 Oncogene 19: 6514–6523

  • Mager AM, Grapin-Botton A, Ladjali K, Meyer D, Wolff CM, Stiegler P, Bonnin MA, Remy P . 1998 Int. J. Dev. Biol. 42: 561–572

  • Magnaghi-Jaulin L, Masutani H, Robin P, Lipinski M, Harel-Bellan A . 1996 Nucleic Acids Res. 24: 1052–1058

  • Mao X, Miesfeldt S, Yang H, Leiden JM, Thompson CB . 1994 J. Biol. Chem. 269: 18216–18222

  • Maroulakou IG, Bowe DB . 2000 Oncogene 19: 6432–6442

  • Mastrangelo T, Modena P, Tornielli S, Bullrich F, Testi MA, Mezzelani A, Radice P, Azzarelli A, Pilotti S, Croce CM, Pierotti MA, Sozzi G . 2000 Oncogene 19: 3799–3804

  • May WA, Arvand A, Thompson AD, Braun BS, Wright M, Denny CT . 1997 Nat. Genet. 17: 495–497

  • May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G, Denny CT . 1993a Proc. Natl. Acad. Sci. USA 90: 5752–5756

  • May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R, Denny CT . 1993b Mol. Cell. Biol. 13: 7393–7398

  • Mélet F, Motro B, Rossi DJ, Zhang L, Bernstein A . 1996 Mol. Cell. Biol. 16: 2708–2718

  • Meyer D, Wolff CM, Stiegler P, Senan F, Befort N, Befort JJ, Remy P . 1993 Mech. Dev. 44: 109–121

  • Mitsiades N, Poulaki V, Leone A, Tsokos M . 1999 J. Natl. Cancer Inst. 91: 1678–1684

  • Morrison SJ, White PM, Zock C, Anderson DJ . 1999 Cell 96: 737–749

  • Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ES . 1994 Oncogene 9: 3087–3097

  • Ohno T, Rao VN, Reddy ES . 1993 Cancer Res. 53: 5859–5863

  • Ouchida M, Ohno T, Fujimura Y, Rao VN, Reddy ES . 1995 Oncogene 11: 1049–1054

  • Panagopoulos I, Hoglund M, Mertens F, Mandahl N, Mitelman F, Aman P . 1996 Oncogene 12: 489–494

  • Pereira R, Quang CT, Lesault I, Dolznig H, Beug H, Ghysdael J . 1999 Oncogene 18: 1597–1608

  • Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Lozzo RV, Cooper DR, Calabretta B . 1998 EMBO J. 17: 4442–4455

  • Perrotti D, Iervolino A, Cesi V, Cirinna M, Lombardini S, Grassilli E, Bonatti S, Claudio PP, Calabretta B . 2000 Mol. Cell. Biol. 20: 6159–6169

  • Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H, Delattre O . 1997 Oncogene 14: 1159–1164

  • Petermann R, Mossier BM, Aryee DN, Khazak V, Golemis EA, Kovar H . 1998 Oncogene 17: 603–610

  • Powers CA, Mathur M, Raaka BM, Ron D, Samuels HH . 1998 Mol. Endocrin. 12: 4–18

  • Prasad DD, Ouchida M, Lee L, Rao VN, Reddy ES . 1994 Oncogene 9: 3717–3729

  • Rabbitts TH, Forster A, Larson R, Nathan P . 1993 Nature Gen. 4: 175–180

  • Rao VN, Ohno T, Prasad DD, Bhattacharya G, Reddy ES . 1993 Oncogene 8: 2167–2173

  • Rauscher FJ, Benjamin LE, Fredericks WJ, Morris JF . 1994 Cold Spring Harb. Symp. Quant. Biol. 59: 137–146

  • Sancéau J, Hiscott J, Delattre O, Wietzerbin J . 2000 Oncogene 19: 3372–3383

  • Sarrazin S, Starck J, Gonnet C, Doubeikovski A, Melet F, Morle F . 2000 Mol. Cell. Biol. 20: 2959–2969

  • Scotlandi K, Baldini N, Cerisano V, Manara MC, Benini S, Serra M, Lollini PL, Nanni P, Nicoletti G, Bernard G, Bernard A, Picci P . 2000a Cancer Res. 60: 5134–5142

  • Scotlandi K, Chano T, Benini S, Serra M, Manara MC, Cerisano V, Picci P, Baldini N . 2000b Intl. J. Cancer 87: 328–335

  • Sjögren H, Meis-Kindblom J, Kindblom LG, Aman P, Stenman G . 1999 Cancer Res. 59: 5064–5067

  • Sohn HW, Choi EY, Kim SH, Lee IS, Chung DH, Sung UA, Hwang DH, Cho SS, Jun BH, Jang JJ, Chi JG, Park SH . 1998 Am. J. Path. 153: 1937–1945

  • Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT . 1994 Nat. Genet. 6: 146–151

  • Sorensen PH, Shimada H, Liu XF, Lim JF, Thomas G, Triche TJ . 1995 Cancer Res. 55: 1385–1392

  • Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, Watson DK . 2000 Mol. Cell. Biol. 20: 5643–5652

  • Stolow DT, Haynes SR . 1995 Nucleic Acids Res. 23: 835–843

  • Tamir A, Howard J, Higgins RR, Li YJ, Berger L, Zacksenhaus E, Reis M, Ben-David Y . 1999 Mol. Cell. Biol. 19: 4452–4464

  • Tanaka K, Iwakuma T, Harimaya K, Sato H, Iwamoto Y . 1997 J. Clin. Invest. 99: 239–247

  • Teitell MA, Thompson AD, Sorensen PH, Shimada H, Triche TJ, Denny CT . 1999 Lab. Invest. 79: 1535–1543

  • Thompson AD, Teitell MA, Arvand A, Denny CT . 1999 Oncogene 18: 5506–5513

  • Thorner P, Squire J, Chilton-MacNeil S, Marrano P, Bayani J, Malkin D, Greenberg M, Lorenzana A, Zielenska M . 1996 Am. J. Pathol. 148: 1125–1138

  • Triche TJ, Askin FB, Kissane JM . 1987 Major Problems in Pathology Vol. 18. Feingold M. and Bennington JC (eds) Saunders: Philadelphia pp. 145–195

    Google Scholar 

  • Truong AHL, Ben-David Y . 2000 Oncogene 19: 6482–6489

  • Turc-Carel C, Philip I, Berger MP, Philip T, Lenoir GM . 1984 Cancer Gen. Cytogen. 12: 1–19

  • Urano F, Umezawa A, Hong W, Kikuchi H, Hata J . 1996 Biochem. Biophys. Res. Commun. 219: 608–612

  • Watson DK, Robinson L, Hodge DR, Kola I, Papas TS, Seth A . 1997 Oncogene 14: 213–221

  • Watson DK, Seth A . 2000 Oncogene 55: 6393–6547

  • Wei G, Antonescu CR, de Alava E, Leung D, Huvos AG, Meyers PA, Healey JH, Ladanyi M . 2000 Cancer 89: 793–799

  • Yang L, Chansky HA, Hickstein DD . 2000a J. Biol. Chem. 275: 37612–37618

  • Yang L, Embree LJ, Hickstein DD . 2000b Mol. Cell. Biol. 20: 3345–3354

  • Yang L, Embree LJ, Tsai S, Hickstein DD . 1998 J. Biol. Chem. 273: 27761–27764

  • Zhang L, Eddy A, Teng YT, Fritzler M, Kluppel M, Melet F, Bernstein A . 1995 Mol. Cell. Biol. 15: 6961–6970

  • Zinszner H, Albalat R, Ron D . 1994 Genes Dev. 8: 2513–2526

  • Zinszner H, Sok J, Immanuel D, Yin Y, Ron D . 1997 J. Cell. Sci. 110: 1741–1750

  • Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christiansen H, Niggli F, Gatterer-Menz I, Smith TL, Jurgens H, Gadner H, Kovar H . 1996 J. Clin. Oncol. 14: 1245–1251

  • Zoubek A, Pfleiderer C, Salzer-Kuntschik M, Amann G, Windhager R, Fink FM, Koscielniak E, Delattre O, Strehl S, Ambros PF, Gadner H, Kovar H . 1994 Br. J. Cancer 70: 908–913

  • Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletchers CD, Aurias A, Thomas G . 1993a Nature Gen. 4: 341–345

  • Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O . 1993b EMBO J. 12: 4481–4487

  • Zwerner JP, May WA . 2001 Oncogene 20: 626–633

Download references

Acknowledgements

This work is supported through the National Institutes of Health grant RO1-87771.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arvand, A., Denny, C. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20, 5747–5754 (2001). https://doi.org/10.1038/sj.onc.1204598

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204598

Keywords

This article is cited by

Search

Quick links